Annual Total Liabilities
$136.87 M
+$38.16 M+38.66%
31 December 2023
Summary:
Intra-Cellular Therapies annual total liabilities is currently $136.87 million, with the most recent change of +$38.16 million (+38.66%) on 31 December 2023. During the last 3 years, it has risen by +$76.42 million (+126.41%). ITCI annual total liabilities is now at all-time high.ITCI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$179.62 M
+$3.73 M+2.12%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly total liabilities is currently $179.62 million, with the most recent change of +$3.73 million (+2.12%) on 30 September 2024. Over the past year, it has increased by +$62.64 million (+53.54%). ITCI quarterly total liabilities is now at all-time high.ITCI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.7% | +53.5% |
| 3 y3 years | +126.4% | +155.8% |
| 5 y5 years | +246.6% | +234.8% |
ITCI Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +126.4% | at high | +155.8% |
| 5 y | 5 years | at high | +246.6% | at high | +253.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Intra-Cellular Therapies Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $179.62 M(+2.1%) |
| June 2024 | - | $175.89 M(+19.2%) |
| Mar 2024 | - | $147.54 M(+7.8%) |
| Dec 2023 | $136.87 M(+38.7%) | $136.87 M(+17.0%) |
| Sept 2023 | - | $116.98 M(+9.8%) |
| June 2023 | - | $106.51 M(+12.7%) |
| Mar 2023 | - | $94.55 M(-4.2%) |
| Dec 2022 | $98.71 M(+37.0%) | $98.71 M(+2.2%) |
| Sept 2022 | - | $96.58 M(+7.7%) |
| June 2022 | - | $89.71 M(+18.3%) |
| Mar 2022 | - | $75.83 M(+5.3%) |
| Dec 2021 | $72.03 M(+19.2%) | $72.03 M(+2.6%) |
| Sept 2021 | - | $70.22 M(-2.6%) |
| June 2021 | - | $72.11 M(+15.7%) |
| Mar 2021 | - | $62.34 M(+3.1%) |
| Dec 2020 | $60.45 M(+7.6%) | $60.45 M(-2.3%) |
| Sept 2020 | - | $61.90 M(+0.8%) |
| June 2020 | - | $61.40 M(+20.9%) |
| Mar 2020 | - | $50.79 M(-9.6%) |
| Dec 2019 | $56.18 M(+42.3%) | $56.18 M(+4.7%) |
| Sept 2019 | - | $53.64 M(+1.0%) |
| June 2019 | - | $53.09 M(-2.3%) |
| Mar 2019 | - | $54.36 M(+37.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $39.49 M(+131.6%) | $39.49 M(+23.6%) |
| Sept 2018 | - | $31.96 M(+47.4%) |
| June 2018 | - | $21.69 M(-3.4%) |
| Mar 2018 | - | $22.45 M(+31.7%) |
| Dec 2017 | $17.05 M(+27.2%) | $17.05 M(+15.6%) |
| Sept 2017 | - | $14.75 M(+49.4%) |
| June 2017 | - | $9.87 M(-48.7%) |
| Mar 2017 | - | $19.27 M(+43.8%) |
| Dec 2016 | $13.40 M(+70.5%) | $13.40 M(-90.6%) |
| Sept 2016 | - | $143.25 M(+562.0%) |
| June 2016 | - | $21.64 M(+98.2%) |
| Mar 2016 | - | $10.92 M(+38.9%) |
| Dec 2015 | $7.86 M(-25.5%) | $7.86 M(-30.2%) |
| Sept 2015 | - | $11.27 M(+14.5%) |
| June 2015 | - | $9.84 M(-33.3%) |
| Mar 2015 | - | $14.75 M(+39.7%) |
| Dec 2014 | $10.56 M(+54.5%) | $10.56 M(+195.1%) |
| Sept 2014 | - | $3.58 M(+30.6%) |
| June 2014 | - | $2.74 M(-30.0%) |
| Mar 2014 | - | $3.91 M(-42.8%) |
| Dec 2013 | $6.83 M(>+9900.0%) | $6.83 M(-12.1%) |
| Sept 2013 | - | $7.77 M(>+9900.0%) |
| June 2013 | - | $33.00 K |
| Mar 2013 | $26.20 K | - |
FAQ
- What is Intra-Cellular Therapies annual total liabilities?
- What is the all time high annual total liabilities for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual total liabilities year-on-year change?
- What is Intra-Cellular Therapies quarterly total liabilities?
- What is the all time high quarterly total liabilities for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly total liabilities year-on-year change?
What is Intra-Cellular Therapies annual total liabilities?
The current annual total liabilities of ITCI is $136.87 M
What is the all time high annual total liabilities for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual total liabilities is $136.87 M
What is Intra-Cellular Therapies annual total liabilities year-on-year change?
Over the past year, ITCI annual total liabilities has changed by +$38.16 M (+38.66%)
What is Intra-Cellular Therapies quarterly total liabilities?
The current quarterly total liabilities of ITCI is $179.62 M
What is the all time high quarterly total liabilities for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly total liabilities is $179.62 M
What is Intra-Cellular Therapies quarterly total liabilities year-on-year change?
Over the past year, ITCI quarterly total liabilities has changed by +$62.64 M (+53.54%)